Oral treatment with enteric-coated pancrelipase and elemental diet

Abstract

The Japanese practice guidelines for the management of chronic pancreatitis were first published in 2009, and the second version was released in 2015. High-potency enteric-coated pancrelipase and elemental diet were newly highlighted in this revised guideline. High-potency enteric-coated pancrelipase has a weak recommendation in curing painful chronic pancreatitis (evidence level B), but has a strong recommendation for the treatment of steatorrhea with weight loss (evidence level A). Elemental diet is an option to treat patients with an attack or recurrent pain, after lifestyle education comprised of abstinence from smoking.